Your gut microbiome and osteoarthritis: the missing link

For most of its history, osteoarthritis research focused on the joint. Cartilage, bone, synovial fluid — the mechanical components of a system under load. The gut was not part of the conversation.

That has changed. A growing body of evidence, now including landmark studies in Science and Nature Communications, has established that the gut microbiome plays a direct role in whether cartilage degrades — and how fast.

The bacteria you may be missing

Among the most significant findings is the consistent depletion of a gut bacterium called Clostridium bolteae in osteoarthritis patients. This was identified through metagenomic sequencing of stool samples from 981 individuals — a large, real-world dataset with a consistent result.

C. bolteae is not a household name. But its function matters. It produces bile acids — specifically UDCA and GUDCA — that trigger a protective signalling cascade ending in the joints themselves. When C. bolteae is depleted, that cascade weakens. The biological protection it provides quietly disappears.

The leaky gut mechanism

A separate but connected mechanism operates through the gut barrier. When the microbial community in the gut shifts out of balance — a state called dysbiosis — the physical integrity of the intestinal lining can be compromised.

When this happens, bacterial byproducts called lipopolysaccharides (LPS) can pass through the gut wall and enter the bloodstream. This triggers chronic low-grade systemic inflammation — sometimes called metaflammation. When these inflammatory signals reach joint tissue, they activate a pathway called NF-κB, which suppresses a protective protein called SHP and drives production of MMP-3 and MMP-13 — enzymes that physically break down cartilage matrix.

Research published in Nature Communications in 2026 identified SHP as a critical natural defender of cartilage. SHP levels decline as osteoarthritis progresses. The gut is upstream of that decline.

Two mechanisms, one origin

What the combined research shows is that the gut microbiome influences joint health through at least two distinct pathways — one through bile acid signalling and GLP-1, one through barrier integrity and inflammatory load. Both fail when the gut microbiome is dysbiotic. Both protect cartilage when the gut environment is healthy.

A 2026 review in Nature Reviews Rheumatology synthesised this evidence and confirmed the gut-joint axis as an established emerging concept in rheumatology — naming next-generation biotics as a key research frontier.

Who is most affected

Gut microbiome diversity and composition change with age. C. bolteae abundance, bile acid profiles, and intestinal barrier integrity all shift over time — typically in directions that reduce joint protection. This is not a disease process in itself. It is a gradual erosion of a biological defence system that most people are unaware exists.

The people most affected by this erosion are often those with no diagnosis — noticing changes in their bodies but finding nothing actionable in a GP appointment. They are in the window where the mechanisms are failing but the damage has not yet become irreversible.

Further reading

Yang et al. (2025). Gut microbiota–bile acid–GLP-1 axis in osteoarthritis. Science. doi:10.1126/science.adt0548

Kang et al. (2026). SHP protects against osteoarthritis by inhibiting IKKβ/NF-κB-mediated matrix-degrading enzymes in chondrocytes. Nature Communications.

[Author et al.] (2026). The gut–joint axis in osteoarthritis. Nature Reviews Rheumatology. doi:10.1038/s41584-026-01378-2

LYVA Flex is formulated around the gut-joint axis described in this article. Read the full science or join the waitlist for founding member pricing.

— William Tyler-Street, Founder